Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

SK&F 108566

Known as: SKF-108566 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

eprosartan

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Antihypertensive activity of the non-peptide angiotensin II receptor antagonist, SK&F 108566, in rats and dogs
SummaryThe antihypertensive activity of the nonpeptide angiotensin II receptor antagonist, SK&F 108566 (E) - α - [[2 - butyl -1… Expand
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
2002
2002
Brain angiotensinergic mediation of enhanced water consumption in lactating rats.
The mechanism by which lactating rats increase fluid consumption to meet the demands of milk production is unknown. Because ANG… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2001
2001
NO/cGMP signaling modulates regulation of Na+-K+-ATPase activity by angiotensin II in rat proximal tubules.
ANG II exerts a biphasic effect on Na+ transport in the kidney through its effects on Na+-K+-ATPase activity. Beginning at 10(-13… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
1998
1998
Determination of SK&F 108566 (Teveten) in human plasma by reversed-phase high-performance liquid chromatography.
A sensitive, selective and rugged analytical method was developed for the determination of SK&F 108566 (eprosartan, Teveten) in… Expand
1998
1998
Angiotensin II signaling activities the NO-cGMP pathway in rat proximal tubules.
We examined the signal transduction cascade of angiotensin II in isolated rat proximal tubules. Angiotensin II induced a rapid… Expand
Highly Cited
1994
Highly Cited
1994
Angiotensin type 1 receptors mediate smooth muscle proliferation and endothelin biosynthesis in rat vascular smooth muscle.
Angiotensin II (AII) has the potential to promote vascular smooth muscle (VSM) hypertrophy and hyperplasia; however, the… Expand
Highly Cited
1992
Highly Cited
1992
Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, SK&F 108566.
The angiotensin II (AII) antagonist activity of (E)-alpha-[[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5- yl]methylene]-2… Expand
1992
1992
Effect of captopril and the nonpeptide angiotensin II antagonists, SK&F 108566 and EXP3174, on renal function in dogs with a renal artery stenosis.
Treatment with an angiotensin converting enzyme (ACE) inhibitor can result in acute renal failure in patients with a renal artery… Expand
Highly Cited
1992
Highly Cited
1992
The antihypertensive effect of the angiotensin II receptor antagonist DuP 753 may not be due solely to angiotensin II receptor antagonism.
The angiotensin II (AII) receptor antagonist, DuP 753 (10 mg/kg intraduodenal), produced a sustained and long-lasting… Expand
1992
1992
Characterization of renal angiotensin II receptors using subtype selective antagonists.
Two angiotensin II (AII) receptor subtypes, AT1 and AT2, have recently been identified based on their relative affinities for… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE